Headaches were more frequent in the HBL group, but this did not reach statistical significance.
← all excerpts
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
1
—
—
Headaches were more frequent in the HBL group, but this did not reach statistical significance.